Advertise your job vacancies
Subscribe & Follow
Jobs
- Mid-level Copywriter Durban
- Junior Multimedia Designer Durban
- Mid-level Multimedia Designer Durban
- Midlevel Social Media Manager Durban
- Area Sales Manager - Eastern Cape Cape Town
- Electrician Cape Town
- Electrical Assistant Cape Town
- Regional Sales Manager Cape Town
- General Assistant Cape Town
- Business Analyst Cape Town
Nestlé to acquire biopharmaceutical company Aimmune
Nestlé Health Science (NHSc) is to acquire Aimmune Therapeutics in accordance with a definitive agreement between Nestlé and the biopharmaceutical company.
NHSc currently has a total investment in Aimmune of $473m, an approximate 25.6% equity ownership stake. The company made its initial investment of $145m in Aimmune in November 2016, followed by further investments of $30m in February 2018, $98m in November 2018 and $200m in January 2020.
Share this inbrief
